These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8287069)

  • 1. Identification of specific intracellular domains of the human ETA receptor required for ligand binding and signal transduction.
    Hashido K; Adachi M; Gamou T; Watanabe T; Furuichi Y; Miyamoto C
    Cell Mol Biol Res; 1993; 39(1):3-12. PubMed ID: 8287069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand binding domain of the human endothelin-B subtype receptor.
    Wada K; Hashido K; Terashima H; Adachi M; Fujii Y; Hiraoka O; Furuichi Y; Miyamoto C
    Protein Expr Purif; 1995 Jun; 6(3):228-36. PubMed ID: 7663155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational analysis of the endothelin type A receptor (ETA): interactions and model of selective ETA antagonist BMS-182874 with putative ETA receptor binding cavity.
    Webb ML; Patel PS; Rose PM; Liu EC; Stein PD; Barrish J; Lach DA; Stouch T; Fisher SM; Hadjilambris O; Lee H; Skwish S; Dickinson KE; Krystek SR
    Biochemistry; 1996 Feb; 35(8):2548-56. PubMed ID: 8611558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Truncation of the receptor carboxyl terminus impairs membrane signaling but not ligand binding of human ETB endothelin receptor.
    Koshimizu T; Tsujimoto G; Ono K; Masaki T; Sakamoto A
    Biochem Biophys Res Commun; 1995 Dec; 217(1):354-62. PubMed ID: 8526934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural insight into the specific interaction between murine SHPS-1/SIRP alpha and its ligand CD47.
    Nakaishi A; Hirose M; Yoshimura M; Oneyama C; Saito K; Kuki N; Matsuda M; Honma N; Ohnishi H; Matozaki T; Okada M; Nakagawa A
    J Mol Biol; 2008 Jan; 375(3):650-60. PubMed ID: 18045614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional domains of human endothelin receptor.
    Adachi M; Hashido K; Trzeciak A; Watanabe T; Furuichi Y; Miyamoto C
    J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S121-4. PubMed ID: 7509921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of ETA and ETB binding domains using ET-derived photoprobes.
    Aubin J; Létourneau M; Francoeur E; Burgeon E; Fournier A
    Biochimie; 2008 Jun; 90(6):918-29. PubMed ID: 18343229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subtype-specific sorting of the ETA endothelin receptor by a novel endocytic recycling signal for G protein-coupled receptors.
    Paasche JD; Attramadal T; Kristiansen K; Oksvold MP; Johansen HK; Huitfeldt HS; Dahl SG; Attramadal H
    Mol Pharmacol; 2005 May; 67(5):1581-90. PubMed ID: 15713850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of residues of the IFNAR1 chain of the type I human interferon receptor critical for ligand binding and biological activity.
    Cajean-Feroldi C; Nosal F; Nardeux PC; Gallet X; Guymarho J; Baychelier F; Sempé P; Tovey MG; Escary JL; Eid P
    Biochemistry; 2004 Oct; 43(39):12498-512. PubMed ID: 15449939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular functions of TC10, a Rho family GTPase: regulation of morphology, signal transduction and cell growth.
    Murphy GA; Solski PA; Jillian SA; Pérez de la Ossa P; D'Eustachio P; Der CJ; Rush MG
    Oncogene; 1999 Jul; 18(26):3831-45. PubMed ID: 10445846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional role of the extracellular N-terminal domain of neuropeptide Y subfamily receptors in membrane integration and agonist-stimulated internalization.
    Lindner D; Walther C; Tennemann A; Beck-Sickinger AG
    Cell Signal; 2009 Jan; 21(1):61-8. PubMed ID: 18845246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased wild-type full-length Et-A and -B receptors in neuroblastoma and Ewing sarcoma cells.
    Berry PA; Zhang YF; Carter ND; Jeffery S; Burchill SA
    Med Pediatr Oncol; 2001 Jan; 36(1):142-6. PubMed ID: 11464869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelin stimulates sis-inducing factor-like DNA binding activity in CHO-K1 cells expressing ETA receptors.
    Peeler TC; Conrad KM; Baker KM
    Biochem Biophys Res Commun; 1996 Apr; 221(1):62-6. PubMed ID: 8660344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ligand binding site of the formyl peptide receptor maps in the transmembrane region.
    Miettinen HM; Mills JS; Gripentrog JM; Dratz EA; Granger BL; Jesaitis AJ
    J Immunol; 1997 Oct; 159(8):4045-54. PubMed ID: 9378994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the receptors for axon guidance factor netrin-4 and identification of the binding domains.
    Qin S; Yu L; Gao Y; Zhou R; Zhang C
    Mol Cell Neurosci; 2007 Feb; 34(2):243-50. PubMed ID: 17174565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An intracellular allosteric site for a specific class of antagonists of the CC chemokine G protein-coupled receptors CCR4 and CCR5.
    Andrews G; Jones C; Wreggett KA
    Mol Pharmacol; 2008 Mar; 73(3):855-67. PubMed ID: 18042736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a ligand-binding site of the human endothelin-A receptor and specific regions required for ligand selectivity.
    Adachi M; Furuichi Y; Miyamoto C
    Eur J Biochem; 1994 Feb; 220(1):37-43. PubMed ID: 8119297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Truncation of N-terminal extracellular or C-terminal intracellular domains of human ETA receptor abrogated the binding activity to ET-1.
    Hashido K; Gamou T; Adachi M; Tabuchi H; Watanabe T; Furuichi Y; Miyamoto C
    Biochem Biophys Res Commun; 1992 Sep; 187(3):1241-8. PubMed ID: 1417800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural mutations of the anti-Mullerian hormone type II receptor found in persistent Mullerian duct syndrome affect ligand binding, signal transduction and cellular transport.
    Belville C; Maréchal JD; Pennetier S; Carmillo P; Masgrau L; Messika-Zeitoun L; Galey J; Machado G; Treton D; Gonzalès J; Picard JY; Josso N; Cate RL; di Clemente N
    Hum Mol Genet; 2009 Aug; 18(16):3002-13. PubMed ID: 19457927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-chimeric analysis of selectivity of secretin and VPAC(1) receptor activation.
    Park CG; Ganguli SC; Pinon DI; Hadac EM; Miller LJ
    J Pharmacol Exp Ther; 2000 Nov; 295(2):682-8. PubMed ID: 11046106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.